BIBP 3226 trifluoroacetate
Tocris Bioscience, part of Bio-Techne | Catalog # 2707
Mixed NPY Y1 and NPFF receptor antagonist
Key Product Details
Description
Mixed NPY Y1 and NPFF receptor antagonist
Product Description
BIBP 3226 trifluoroacetate is a mixed non-peptide neuropeptide Y Y1 (NPY Y1) and neuropeptide FF (NPFF) receptor antagonist (Ki values are 1.1, 79, 108, > 1000, > 1000 and >1000 for rNPY Y1, hNPFF2, rNPFF, rNPY Y2, rNPY Y4 and rNPY Y5 respectively). Produces an anxiogenic-like effect in rats following i.c.v. administration.Important Information
This product is sold as a TFA salt. The stoichiometry of the salt and hydration levels vary from batch to batch. This product is sold in gross weight with the batch specific Net Product Content (free base) available on the Certificate of AnalysisProduct Specifications
Formula
C27H31N5O3.xCF3CO2H
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
N-[(1R)]-4-[(Aminoiminomethyl)amino-1-[[[(4-hydroxyphenyl)methyl]amino]carbonyl]butyl-α-phenylbenzeneacetamide trifluoroacetate
PubChem ID
121513845
InChI Key
FSBMUMHPXBMVJF-MQWQBNKOSA-N
SMILES
OC1=CC=C(CNC([C@H](NC(C(C2=CC=CC=C2)C3=CC=CC=C3)=O)CCCNC(N)=N)=O)C=C1.OC(C(F)(F)F)=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solubility | Soluble to 1mg/ml in water and to 50mg/ml in DMSO |
Calculators
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Mollereau Agonist and antagonist activities on human NPFF2 receptors of the NPY ligands GR231118 and BIBP3226. Br.J.Pharmacol. 2001 PMID: 11325787
- Fang In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist. Peptides 2006 PMID: 16762456
- Kask Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with D.pam. Eur.J.Pharmacol. 1996 PMID: 8997632
Product Specific Notices for BIBP 3226 trifluoroacetate
For research use only
Loading...
Loading...